• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Imisopasem manganese

CAS No. 218791-21-0

Imisopasem manganese ( M-40403 | GC-4419 )

产品货号. M13490 CAS No. 218791-21-0

Imisopasem manganese (M40403) 是稳定的 MnSOD 的非肽基模拟物。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
50MG ¥6569 有现货
100MG ¥8060 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Imisopasem manganese
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Imisopasem manganese (M40403) 是稳定的 MnSOD 的非肽基模拟物。
  • 产品描述
    A small-molecule superoxide dismutase (SOD) mimetic that converts superoxide to hydrogen peroxide and molecular oxygen; significantly mitigates the increased sensitivity of old fibroblasts to ionizing radiation and chemotherapy and partially restores mitochondrial function without affecting ionizing radiation or chemotherapy-induced cancer cell killing.Chemotherapeutic Agents Phase 2 Clinical.
  • 体外实验
    Imisopasem manganese is a small molecule, synthetic manganese containing superoxide dismutase mimetic (SODm) that removes superoxide anions without interfering with other reactive species known to be involved in inflammatory responses (e.g. nitric oxide, NO and peroxynitrite, ONOO-).
  • 体内实验
    Imisopasem manganese is a small-molecule superoxide dismutase mimetic that has shown efficacy in animal model disease states in which superoxide anions are thought to play a key role. Imisopasem manganese inhibits the inflammatory response following the intrapleural injection of carrageenan in rats. All parameters of inflammation are attenuated by Imisopasem manganese except for NOx, PGE2 and IL-10 which remains unaltered. Decreased apoptosis of the large and particularly the small bowel and marked recovery of both lymphoid and hematopoietic tissues occurs in the Imisopasem manganese pre-treated mice. Imisopasem manganese is effective in reducing TBI-induced tissue destruction and has potential as a new radioprotective agent.
  • 同义词
    M-40403 | GC-4419
  • 通路
    Others
  • 靶点
    Other Targets
  • 受体
    Other Targets
  • 研究领域
    Cancer
  • 适应症
    Chemotherapeutic

化学信息

  • CAS Number
    218791-21-0
  • 分子量
    479.348385
  • 分子式
    C21H31Cl2MnN5
  • 纯度
    >98% (HPLC)
  • 溶解度
    H2O: 16 mg/mL (Need ultrasonic and warming)
  • SMILES
    [H][N@]1([C@H]2[C@H]3CCCC2)CC4=[N]5C(C[N]6([H])[C@H]7CCCC[C@H]7[N@@]([Mn]861(Cl)5Cl)([H])CC[N@@]38[H])=CC=C4
  • 化学全称
    Manganese, dichloro[(4aR,13aR,17aR,21aR)-1,2,3,4,4a,5,6,12,13,13a,14,15,16,17,17a,18,19,20,21,21a-eicosahydro-11,7-nitrilo-7H-dibenzo[b,h][1,4,7,10]tetraazacycloheptadecine-κN5,κN13,κN18,κN21,κN22]-, (PB-7-11-2344'3')-

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Tuder RM, et al. Am J Respir Cell Mol Biol. 2003 Jul;29(1):88-97. 2. Mapuskar KA, et al. Cancer Res. 2017 Aug 1. pii: canres.0106.2017.
产品手册
关联产品
  • 3,5,7-Trihydroxychro...

    3,5,7-Trihydroxychromone exhibits weak antiangiogenic activity.

  • Ciwujianoside A1

    刺五加苷A1来自刺五加。

  • 6,7,4'-Trihydroxyfla...

    6,7,4'-三羟基黄烷酮具有多种药理活性,包括抗风湿、抗缺血、抗炎、抗破骨细胞生成以及对 METH 诱导的 T 细胞失活的保护作用。 6,7,4'-三羟基黄烷酮可用于治疗患有神经退行性疾病的冰毒成瘾者的研究。